Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 7,221 | 126,725 | 5,263 | 5,718 | 17,564 |
| Gross Profit | 7,221 | 126,725 | 5,263 | 5,718 | 17,564 |
| Operating Expenses | 56,653 | 58,318 | 53,405 | 41,044 | 35,462 |
| Operating Income | -49,432 | 68,407 | -48,142 | -35,326 | -17,898 |
| Interest Expense | 738 | 744 | 732 | 696 | 759 |
| Other Income | 169 | 555 | 544 | 557 | 405 |
| Pre-tax Income | -50,001 | 68,218 | -48,330 | -35,465 | -18,252 |
| Net Income Continuous | -50,001 | 68,218 | -48,330 | -35,465 | -18,252 |
| Net Income | $-50,001 | $68,218 | $-48,330 | $-35,465 | $-18,252 |
| EPS Basic Total Ops | -10.80 | 14.80 | -10.60 | -7.80 | -4.00 |
| EPS Basic Continuous Ops | -10.88 | 14.87 | -10.55 | -7.75 | -3.83 |
| EPS Diluted Total Ops | -10.40 | 14.40 | -10.60 | -7.80 | -4.00 |
| EPS Diluted Continuous Ops | -10.38 | 14.37 | -10.55 | -7.75 | -3.83 |
| EBITDA(a) | $-47,321 | $70,543 | $-45,863 | $-32,881 | $-15,287 |